Washington § 69.50.455 Synthetic cannabinoids—Unfair or deceptive practice under RCW19.86.020.

Washington Statutes

§ 69.50.455 — Synthetic cannabinoids—Unfair or deceptive practice under RCW19.86.020.

Washington § 69.50.455

Title 69FOOD, DRUGS, COSMETICS, AND POISONS

Ch. 69.50UNIFORM CONTROLLED SUBSTANCES ACT

This text of Washington § 69.50.455 (Synthetic cannabinoids—Unfair or deceptive practice under RCW19.86.020.) is published on Counsel Stack Legal Research, covering Washington primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

Wash. Rev. Code § 69.50.455 (2026).

Text

(1)It is an unfair or deceptive practice under RCW 19.86.020 for any person or entity to distribute, dispense, manufacture, display for sale, offer for sale, attempt to sell, or sell to a purchaser any product that contains any amount of any synthetic cannabinoid. The legislature finds that practices covered by this section are matters vitally affecting the public interest for the purpose of applying the consumer protection act, chapter 19.86 RCW. Violations of this section are not reasonable in relation to the development and preservation of business.

(2)"Synthetic cannabinoid" includes any chemical compound identified in RCW 69.50.204 (c)(30) [(3)(dd)] or by the pharmacy quality assurance commission under RCW 69.50.201 . Findings — Intent — Effective dates — 2015 2nd sp.s. c 4: See n

Free access — add to your briefcase to read the full text and ask questions with AI

(1) It is an unfair or deceptive practice under RCW 19.86.020 for any person or entity to distribute, dispense, manufacture, display for sale, offer for sale, attempt to sell, or sell to a purchaser any product that contains any amount of any synthetic cannabinoid. The legislature finds that practices covered by this section are matters vitally affecting the public interest for the purpose of applying the consumer protection act, chapter 19.86 RCW. Violations of this section are not reasonable in relation to the development and preservation of business.

(2) "Synthetic cannabinoid" includes any chemical compound identified in RCW 69.50.204 (c)(30) [(3)(dd)] or by the pharmacy quality assurance commission under RCW 69.50.201 .

Findings — Intent — Effective dates — 2015 2nd sp.s. c 4: See notes following RCW 69.50.334 .